Royds JA - Search Results

1

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA. Hakin-Smith V, et al. Among authors: royds ja. Lancet. 2003 Mar 8;361(9360):836-8. doi: 10.1016/s0140-6736(03)12681-5. Lancet. 2003. PMID: 12642053

2

Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.

Carroll T, Maltby E, Brock I, Royds J, Timperley W, Jellinek D. Carroll T, et al. J Pathol. 1999 Aug;188(4):395-9. doi: 10.1002/(SICI)1096-9896(199908)188:4<395::AID-PATH376>3.0.CO;2-E. J Pathol. 1999. PMID: 10440750

3

Molecular markers and long-term survivors of glioblastoma multiforme.

McKay MJ, MacCallum P, Reddel RR, Royds J. McKay MJ, et al. Cancer J. 2004 Sep-Oct;10(5):333. doi: 10.1097/00130404-200409000-00011. Cancer J. 2004. PMID: 15530263 No abstract available.

4

Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.

Hakin-Smith V, Battersby RD, Maltby EL, Timperley WR, Royds JA. Hakin-Smith V, et al. Among authors: royds ja. Neuropathol Appl Neurobiol. 2001 Feb;27(1):40-9. doi: 10.1046/j.0305-1846.2001.00300.x. Neuropathol Appl Neurobiol. 2001. PMID: 11299001 Clinical Trial.

5

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE, Reddel RR. Henson JD, et al. Among authors: royds ja. Clin Cancer Res. 2005 Jan 1;11(1):217-25. Clin Cancer Res. 2005. PMID: 15671549

6

Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.

Chen YJ, Hakin-Smith V, Teo M, Xinarianos GE, Jellinek DA, Carroll T, McDowell D, MacFarlane MR, Boet R, Baguley BC, Braithwaite AW, Reddel RR, Royds JA. Chen YJ, et al. Among authors: royds ja. Cancer Res. 2006 Jul 1;66(13):6473-6. doi: 10.1158/0008-5472.CAN-06-0910. Cancer Res. 2006. PMID: 16818615

7

Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.

McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A, Wheeler HR, Cook RJ, Biggs MT, Little NS, Robinson BG, Reddel RR, Royds JA. McDonald KL, et al. Among authors: royds ja. J Neuropathol Exp Neurol. 2010 Jul;69(7):729-36. doi: 10.1097/NEN.0b013e3181e576cf. J Neuropathol Exp Neurol. 2010. PMID: 20535033

8

Detection of alternative lengthening of telomeres by telomere quantitative PCR.

Lau LM, Dagg RA, Henson JD, Au AY, Royds JA, Reddel RR. Lau LM, et al. Among authors: royds ja. Nucleic Acids Res. 2013 Jan;41(2):e34. doi: 10.1093/nar/gks781. Epub 2012 Aug 25. Nucleic Acids Res. 2013. PMID: 22923525 Free PMC article.

9

Effect of interleukin-1 and dexamethasone on interleukin-6 production and growth in human meningiomas.

Jones TH, Justice SK, Timperley WR, Royds JA. Jones TH, et al. Among authors: royds ja. J Pathol. 1997 Dec;183(4):460-8. doi: 10.1002/(SICI)1096-9896(199712)183:4<460::AID-PATH961>3.0.CO;2-Z. J Pathol. 1997. PMID: 9496264

10

IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas.

Suliman ME, Royds JA, Baxter L, Timperley WR, Cullen DR, Jones TH. Suliman ME, et al. Among authors: royds ja. Eur J Endocrinol. 1999 Feb;140(2):155-8. doi: 10.1530/eje.0.1400155. Eur J Endocrinol. 1999. PMID: 10069660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page